90% of pharmaceutical professionals believe business environment is positive

8 October 2012

According to a pre-event survey by UBM Live ahead of the CPhI Worldwide 2012 meeting, 97% of visitors expect sales to increase or stay the same over the next 12 months (up from 90% over the last 12 months), and 90% rate their business opportunity in the global pharmaceutical market positively.

Attendees expect pockets of innovation to positively impact their overall business including GMP certification (64.8%), the rise in generics (58.6%), the move toward outsourcing (53.4%) and supply chain security (50.4%). The visitors polled represent pharmaceutical buyers who plan to attend CPhI Worldwide, set for October 9-11 at the Feria de Madrid in Spain. CPhI and co-located events ICSE, InnoPack and P-MEC Europe host 2,200 suppliers offering ingredients, finished dosage, contract services, equipment, and packaging.

"As part of our ongoing commitment to driving growth and innovation in the global pharmaceutical market, CPhI provides an efficient and effective platform for the most active buyers to identify business opportunities and meet with potential partners to move the industry forward," commented CPhI Portfolio director, Greg Kerwin, adding: "Despite global economic uncertainly, we are enthused to see such optimism and focus on innovation from the leaders in the pharmaceutical industry."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical